FDA OKs Experimental Regeneron Drug To Help Prevent COVID-19 Hospitalization - WUSF Public Media | Tampa NPR, Local News Coverage

FDA OKs Experimental Regeneron Drug To Help Prevent COVID-19 Hospitalization

REGENERON

U.S. health officials have allowed emergency use of a second antibody drug to help the immune system fight COVID-19.

The Food and Drug Administration on Saturday authorized use of the Regeneron Pharmaceuticals Inc. drug for people with mild-to-moderate symptoms.

Tests of the drug are continuing, but early results suggest it may prevent hospitalization and emergency room visits.

Use is allowed for adults and children 12 and over who are at high risk of severe illness from COVID-19 because of age or certain other medical conditions.

The Regeneron drug is a combo of two antibodies to enhance the chances it will prove effective.

It’s an experimental medicine that President Donald Trump was given when he was sickened last month.

Ultimate Medical Academy